AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32701847 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 59
Study 32701847 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-paced breathing
Number of subjects: 59
Study 32701847 — intervention group
Group type: COMPARATOR
Intervention: Sham mindfulness meditation
Number of subjects: 59
Study 36007566 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster 3 (young men with obesity and diabetes)
Number of subjects: 812
Study 36007566 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster 4 (low resting blood pressure)
Number of subjects: 812
Study 36007566 — intervention group
Group type: EXPERIMENTAL
Intervention: LCA Cluster B (younger men with few comorbidities)
Number of subjects: 812
Study 36007566 — intervention group
Group type: EXPERIMENTAL
Intervention: LCA Cluster C (older individuals with AF and renal impairment)
Number of subjects: 812
Study 32697858 — intervention group
Group type: EXPERIMENTAL
Intervention: Autophagy-activating peptide
Number of subjects: 0
Study 32697858 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 35112011 — intervention group
Group type: EXPERIMENTAL
Intervention: ReDeSign online dementia training program (n = 62)
Number of subjects: 124
Study 35112011 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 62)
Number of subjects: 124
Study 32388198 — intervention group
Group type: EXPERIMENTAL
Intervention: Xpert MTB/RIF
Number of subjects: 1265
Study 32388198 — intervention group
Group type: COMPARATOR
Intervention: Sputum AFB smear
Number of subjects: 1265
Study 36367711 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy
Number of subjects: 14
Study 33693907 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone treatment (injectable testosterone undecanoate)
Number of subjects: 601
Study 33693907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 601
Study 32610640 — intervention group
Group type: EXPERIMENTAL
Intervention: Be a Mom (web-based self-guided intervention)
Number of subjects: 367
Study 32610640 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 367
Study 36027670 — intervention group
Group type: EXPERIMENTAL
Intervention: Femistina (40 mg, oral, twice daily for 20 days)
Number of subjects: 320
Study 36027670 — intervention group
Group type: COMPARATOR
Intervention: Canephron (3 × 5 ml taken orally three times daily for 4 weeks)
Number of subjects: 320
Study 34022636 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed dose of 4-factor prothrombin complex concentrate (4FPCC) at 1500 IU
Number of subjects: 71
Study 34022636 — intervention group
Group type: COMPARATOR
Intervention: Variable dosing of 4-factor prothrombin complex concentrate (4FPCC)
Number of subjects: 71
Study 32662200 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey
Number of subjects: 32
Study 32662200 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit juice
Number of subjects: 32
Study 32662200 — intervention group
Group type: COMPARATOR
Intervention: Sugar cubes
Number of subjects: 32
Study 34379122 — intervention group
Group type: EXPERIMENTAL
Intervention: SUPA intervention utilizing cognitive behavioral and motivational interviewing techniques
Number of subjects: 0
Study 34404144 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-implant assisted rapid palatal expansion (MARPE) in fusion group
Number of subjects: 28
Study 34404144 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-implant assisted rapid palatal expansion (MARPE) in non-fusion group
Number of subjects: 28
Study 34285004 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics (penicillins, cephalosporins, macrolides)
Number of subjects: 432
Study 32916306 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transfer (FMT) from post-Roux-en-Y gastric bypass (RYGB) donors
Number of subjects: 24
Study 32916306 — intervention group
Group type: COMPARATOR
Intervention: Oral butyrate supplementation
Number of subjects: 24
Study 35081440 — intervention group
Group type: EXPERIMENTAL
Intervention: XP-endo Shaper (XPS) with 10 pecking motions
Number of subjects: 45
Study 35081440 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciproc Blue (RB) with 4 pecking motions
Number of subjects: 45
Study 35081440 — intervention group
Group type: EXPERIMENTAL
Intervention: WaveOne Gold (WOG) with 4 pecking motions
Number of subjects: 45
Study 34649825 — intervention group
Group type: COMPARATOR
Intervention: Resistance Training (RT)
Number of subjects: 248
Study 34649825 — intervention group
Group type: COMPARATOR
Intervention: Aerobic Training (AT)
Number of subjects: 248
Study 34649825 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 248
Study 35071600 — intervention group
Group type: EXPERIMENTAL
Intervention: MitoQ (20 mg/day, oral)
Number of subjects: 52
Study 35071600 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Training (ET) (cycle ergometer, moderate intensity, 40-60% VO2 peak, heart rate 120-140 b/min, 45 min a day, three days/week for six weeks)
Number of subjects: 52
Study 35071600 — intervention group
Group type: EXPERIMENTAL
Intervention: MitoQ + ET
Number of subjects: 52
Study 35071600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 33849510 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual mapping techniques (mind mapping & concept mapping) after each community-based teaching session
Number of subjects: 60
Study 33849510 — intervention group
Group type: COMPARATOR
Intervention: Conventional method (Question-Answer session with built-in discussion)
Number of subjects: 60
Study 33472786 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor control exercises
Number of subjects: 414
Study 33472786 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded activity
Number of subjects: 414
Study 33371104 — intervention group
Group type: EXPERIMENTAL
Intervention: Whitacre needle
Number of subjects: 164
Study 33371104 — intervention group
Group type: COMPARATOR
Intervention: Chiba needle
Number of subjects: 164
Study 35946246 — intervention group
Group type: EXPERIMENTAL
Intervention: tell‐show‐play‐doh
Number of subjects: 125
Study 35946246 — intervention group
Group type: EXPERIMENTAL
Intervention: Playmobil Dentist
Number of subjects: 125
Study 35946246 — intervention group
Group type: EXPERIMENTAL
Intervention: mobile dentist games
Number of subjects: 125
Study 35946246 — intervention group
Group type: EXPERIMENTAL
Intervention: role play as dentist
Number of subjects: 125
Study 35946246 — intervention group
Group type: COMPARATOR
Intervention: tell‐show‐do
Number of subjects: 125
Study 32584091 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentalization-based treatment (MBT)
Number of subjects: 134
Study 32584091 — intervention group
Group type: COMPARATOR
Intervention: Structured clinical management (SCM)
Number of subjects: 134
Study 32920164 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT-based mobile application (4 min daily exercises for two weeks)
Number of subjects: 90
Study 32920164 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 90
Study 36174627 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant S-1 plus endocrine therapy
Number of subjects: 0
Study 36174627 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33621782 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-Led Self-Management (PLSM) program for 4 weeks
Number of subjects: 28
Study 33621782 — intervention group
Group type: COMPARATOR
Intervention: Control group received a self-management manual and usual clinical care
Number of subjects: 28
Study 32150151 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (atDCS) over S1
Number of subjects: 30
Study 32150151 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (ctDCS) over M1
Number of subjects: 30
Study 32150151 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (stDCS) over M1
Number of subjects: 30
Study 32150151 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (stDCS) over S1
Number of subjects: 30
Study 32150151 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (atDCS) over M1
Number of subjects: 30
Study 32150151 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (ctDCS) over S1
Number of subjects: 30
Study 32546430 — intervention group
Group type: EXPERIMENTAL
Intervention: Newborn screening (NBS) group, 57 subjects
Number of subjects: 104
Study 32546430 — intervention group
Group type: COMPARATOR
Intervention: Control group, 47 subjects
Number of subjects: 104
Study 32546430 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 104
Study 32499312 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quintile of Empirical Dietary Index for Hyperinsulinemia (EDIH)
Number of subjects: 1024
Study 34813901 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplement (20 g whey protein + 800 IU vitamin D)
Number of subjects: 49
Study 34813901 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity (brisk walking, muscle-strengthening exercises for lower limbs, balance training)
Number of subjects: 49
Study 34813901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 33894365 — intervention group
Group type: EXPERIMENTAL
Intervention: Interscalene nerve block (INB)
Number of subjects: 108
Study 33894365 — intervention group
Group type: COMPARATOR
Intervention: Local liposomal bupivacaine (LLB)
Number of subjects: 108
Study 32585263 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective caries removal to soft dentin (SCRSD)
Number of subjects: 172
Study 32585263 — intervention group
Group type: COMPARATOR
Intervention: Stepwise excavation (SW)
Number of subjects: 172
Study 32585263 — intervention group
Group type: EXPERIMENTAL
Intervention: Amalgam (AM)
Number of subjects: 172
Study 32585263 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin composite (RC)
Number of subjects: 172
Study 36114020 — intervention group
Group type: EXPERIMENTAL
Intervention: ARRY-371797 (PF-07265803)
Number of subjects: 8
Study 36114020 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 8
Study 35777413 — intervention group
Group type: EXPERIMENTAL
Intervention: [18F]FDG-PET-CT
Number of subjects: 147
Study 35777413 — intervention group
Group type: COMPARATOR
Intervention: CT
Number of subjects: 147
Study 36254014 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX group)
Number of subjects: 54
Study 36254014 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (CON group)
Number of subjects: 54
Study 33984536 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequency nrTMS (1 Hz, 15 min)
Number of subjects: 0
Study 33984536 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 32612085 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening-only low-carbohydrate meal (LCM) at 1800 h
Number of subjects: 14
Study 32612085 — intervention group
Group type: COMPARATOR
Intervention: Standard test meals (STMs)
Number of subjects: 14
Study 33735416 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (1 mg BID for 12 weeks)
Number of subjects: 0
Study 33735416 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 33253294 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 48389
Study 33253294 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 48389
Study 33253294 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 48389
Study 33253294 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 48389
Study 33423990 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) applied for 5 weeks, one session per week
Number of subjects: 52
Study 33423990 — intervention group
Group type: COMPARATOR
Intervention: Low-level laser therapy (LLLT) applied with 15 sessions on consecutive days
Number of subjects: 52
Study 35487860 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (INT): Reduced sedentary behavior by 50 min/day
Number of subjects: 64
Study 35487860 — intervention group
Group type: COMPARATOR
Intervention: Control (CON): Maintained baseline activity levels
Number of subjects: 64
Study 34144031 — intervention group
Group type: EXPERIMENTAL
Intervention: SexHealth intervention
Number of subjects: 91
Study 34144031 — intervention group
Group type: COMPARATOR
Intervention: Printed materials (control)
Number of subjects: 91
Study 35578655 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactively controllable graphics on the spread of COVID-19 and information on physical distancing
Number of subjects: 817
Study 35578655 — intervention group
Group type: COMPARATOR
Intervention: Text-based information about quantitative evidence
Number of subjects: 817
Study 35976021 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapinarof 1% cream applied once daily for 12 weeks
Number of subjects: 0
Study 35976021 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 33498159 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive treatment at both metastatic and primary sites (Group A)
Number of subjects: 67
Study 33498159 — intervention group
Group type: COMPARATOR
Intervention: Non-aggressive treatment (Group B)
Number of subjects: 67
Study 33498159 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients not treated with PD-L1 inhibitors
Number of subjects: 67
Study 35459599 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser acupuncture (LA)
Number of subjects: 82
Study 35459599 — intervention group
Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 82
Study 33000439 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexually arousing film clip
Number of subjects: 90
Study 33000439 — intervention group
Group type: COMPARATOR
Intervention: Emotionally neutral film clip
Number of subjects: 90
Study 35266589 — intervention group
Group type: EXPERIMENTAL
Intervention: TXA 15 mg/kg bolus dose, followed by 2 mg/kg/hr infusion over 8 hours
Number of subjects: 31
Study 35266589 — intervention group
Group type: EXPERIMENTAL
Intervention: TXA 30 mg/kg bolus dose, followed by 4 mg/kg/hr infusion over 8 hours
Number of subjects: 31
Study 35266589 — intervention group
Group type: COMPARATOR
Intervention: Normal saline placebo bolus and infusion
Number of subjects: 31
Study 34031759 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 280
Study 34031759 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin-hydroxychloroquine
Number of subjects: 280
Study 34031759 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study 34040108 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-61803534 (oral formulation)
Number of subjects: 0
Study 34040108 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-61803534 (in mouse models)
Number of subjects: 0
Study 35316429 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nursing intervention based on a comprehensive geriatric assessment (CGA)
Number of subjects: 92
Study 35316429 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing (Control)
Number of subjects: 92
Study 32009005 — intervention group
Group type: EXPERIMENTAL
Intervention: Twin block
Number of subjects: 40
Study 32009005 — intervention group
Group type: COMPARATOR
Intervention: Trigger point injections
Number of subjects: 40
Study 34537829 — intervention group
Group type: EXPERIMENTAL
Intervention: salvinorin-A
Number of subjects: 2
Study 34537829 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2
Study 32306100 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 20
Study 32306100 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CT) - Stretching exercises
Number of subjects: 20
Study 96005583 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactitol
Number of subjects: 10
Study 33705531 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 30507
Study 33705531 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 30507
Study 32143828 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrus Microstent (HMS)
Number of subjects: 556
Study 32143828 — intervention group
Group type: COMPARATOR
Intervention: Cataract surgery alone (no microstent [NMS])
Number of subjects: 556
Study 35954850 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic psychotherapy treatment over 28 sessions
Number of subjects: 62
Study 35954850 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeling-Word Checklist-28 (FWC-28)
Number of subjects: 62
Study 33252075 — intervention group
Group type: EXPERIMENTAL
Intervention: Verubecestat
Number of subjects: 1785
Study 33252075 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1785
Study 35943788 — intervention group
Group type: EXPERIMENTAL
Intervention: Customization of the AirHeart app (personalizing a virtual avatar and travel vehicle)
Number of subjects: 94
Study 35943788 — intervention group
Group type: COMPARATOR
Intervention: No customization of the AirHeart app
Number of subjects: 94
Study 35943788 — intervention group
Group type: EXPERIMENTAL
Intervention: AirHeart app features (journaling, mood tracking, reminders)
Number of subjects: 94
Study 35943788 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatar identification
Number of subjects: 94
Study 33904295 — intervention group
Group type: EXPERIMENTAL
Intervention: Short course antibiotics (1g of ceftriaxone with 500mg of metronidazole stat post umbilical cord clamping)
Number of subjects: 166
Study 33904295 — intervention group
Group type: COMPARATOR
Intervention: Long course antibiotics (post-operative doses of intravenous ceftriaxone 1g 12 hourly with 500mg of metronidazole eight hourly for 24 hours, then oral cefuroxime 500mg twice daily and metronidazole 400mg thrice daily for five days)
Number of subjects: 166
Study 33904295 — intervention group
Group type: EXPERIMENTAL
Intervention: Short course antibiotics
Number of subjects: 166
Study 33904295 — intervention group
Group type: COMPARATOR
Intervention: Long course antibiotics
Number of subjects: 166
Study 35717403 — intervention group
Group type: EXPERIMENTAL
Intervention: PETReA trial during COVID-19
Number of subjects: 41
Study 35717403 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative discussions about risks and benefits of randomisation
Number of subjects: 41
Study 35717403 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial communication strategies
Number of subjects: 41
Study 34689847 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids from flaxseed oil
Number of subjects: 0
Study 35561440 — intervention group
Group type: COMPARATOR
Intervention: Olfactory home test using household items
Number of subjects: 50
Study 35561440 — intervention group
Group type: COMPARATOR
Intervention: CPS-C(de)
Number of subjects: 50
Study 32054483 — intervention group
Group type: EXPERIMENTAL
Intervention: Wharton's jelly formulation
Number of subjects: 0
Study 34030555 — intervention group
Group type: EXPERIMENTAL
Intervention: BDP 200 µg BID
Number of subjects: 610
Study 34030555 — intervention group
Group type: EXPERIMENTAL
Intervention: BDP 50 µg BID
Number of subjects: 610
Study 34030555 — intervention group
Group type: EXPERIMENTAL
Intervention: BDP 400 µg BID
Number of subjects: 610
Study 34030555 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 610
Study 34030555 — intervention group
Group type: EXPERIMENTAL
Intervention: QVAR® 160 µg BID
Number of subjects: 610
Study 34276328 — intervention group
Group type: EXPERIMENTAL
Intervention: Active VNS stimulation (2–5 mA, once a week for 1 hour for 12 weeks)
Number of subjects: 120
Study 34276328 — intervention group
Group type: COMPARATOR
Intervention: Dummy stimulation (same parameters as active VNS but at an irrelevant anatomical site)
Number of subjects: 120
Study 35956333 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietitian-led behavior counselling sessions
Number of subjects: 101
Study 35956333 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest lean mass index z-score at 9 months
Number of subjects: 101
Study 35956333 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 101
Study 33634478 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-dose facilitated PCI strategy (reduced-dose fibrinolysis combined with simultaneous transfer for immediate invasive therapy with a time interval between fibrinolysis to PCI < 3 hours)
Number of subjects: 632
Study 33634478 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmacoinvasive treatment
Number of subjects: 632
Study 34908192 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine ER
Number of subjects: 62
Study 34908192 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 33257178 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepping Stones and Creating Futures intervention
Number of subjects: 674
Study 33257178 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 674
Study 34709497 — intervention group
Group type: EXPERIMENTAL
Intervention: HS016
Number of subjects: 0
Study 34709497 — intervention group
Group type: COMPARATOR
Intervention: adalimumab
Number of subjects: 0
Study 33392835 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib + endocrine therapy (ET)
Number of subjects: 1152
Study 33392835 — intervention group
Group type: COMPARATOR
Intervention: Placebo + endocrine therapy (ET)
Number of subjects: 1152
Study 33392835 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib + ET
Number of subjects: 1152
Study 33392835 — intervention group
Group type: COMPARATOR
Intervention: Placebo + ET
Number of subjects: 1152
Study 32876791 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice wrap
Number of subjects: 59
Study 32876791 — intervention group
Group type: EXPERIMENTAL
Intervention: Subacromial injection
Number of subjects: 59
Study 32876791 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study 37057581 — intervention group
Group type: EXPERIMENTAL
Intervention: Chamomile vaginal gel 5%
Number of subjects: 96
Study 37057581 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogen vaginal cream
Number of subjects: 96
Study 37057581 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaginal gel
Number of subjects: 96
Study 33970291 — intervention group
Group type: EXPERIMENTAL
Intervention: Legal, prescribed cannabis
Number of subjects: 678